
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+4
Leveraging the possibilities of modern science and advanced technologies, BioPhy is committed to transforming the way promising drugs are identified, developed, and tested. With the help of our patent-pending predictive AI engine BioLogic, and our generative AI solution BioPhyRx, we work to enhance the outcomes of clinical trials, reduce failure and non-compliance rates, accelerate the pace of developing new drugs, and moreover, improve the quality of healthcare outcomes across the globe. Meet the founders: Dave Latshaw II, Ph.D.: https://www.linkedin.com/in/davidlatshawii/ Steve Truong: https://www.linkedin.com/in/stevenhtruong1 Daniel Sciubba, MD: https://www.linkedin.com/in/daniel-sciubba-md-wharton-mba-cand BioPhy is a Philadelphia-based, venture backed company. Contact us at info@biophy.ai
Ai,innovation,healthcare,clinical trials,ai drug development,generative ai,regulatory intelligence,quality intelligence,and search and evaluation
Biophy operates in the Biotechnology research industry.
Biophy's revenue is 11m - 100m
Biophy has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.